Association of MR-proadrenomedullin with cardiovascular risk factors and subclinical cardiovascular disease

被引：48

作者：

Neumann, Johannes Tobias ^{[1
]}

Tzikas, Stergios ^{[2
]}

Funke-Kaiser, Anne ^{[1
]}

Wilde, Sandra ^{[1
]}

Appelbaum, Sebastian ^{[1
]}

Keller, Till ^{[1
]}

Ojeda-Echevarria, Francisco ^{[1
]}

Zeller, Tanja ^{[1
]}

Zwiener, Isabella ^{[3
]}

Sinning, Christoph R. ^{[1
]}

Jagodzinski, Annika ^{[1
]}

Schnabel, Renate B. ^{[1
]}

Lackner, Karl J. ^{[4
]}

Muenzel, Thomas

Blankenberg, Stefan ^{[1
]}

Wild, Philipp S. ^{[2
,5
]}

Sydow, Karsten ^{[1
]}

机构：

[1] Univ Hamburg, Ctr Heart, Dept Gen & Intervent Cardiol, D-20246 Hamburg, Germany

[2] Univ Med Ctr Mainz, Dept Med 2, Mainz, Germany

[3] Univ Med Ctr Mainz, Inst Med Biostat Epidemiol & Informat, Mainz, Germany

[4] Univ Med Ctr Mainz, Inst Clin Chem & Lab Med, Mainz, Germany

[5] Univ Med Ctr Mainz, Ctr Thrombosis & Haemostasis, Mainz, Germany

来源：

ATHEROSCLEROSIS | 2013年 / 228卷 / 02期

关键词：

Biomarker; Adrenomedullin; Cardiovascular disease; Cardiovascular risk factors; Reference values; REGIONAL PRO-ADRENOMEDULLIN; HEART-FAILURE; MIDREGIONAL PROADRENOMEDULLIN; HYPOTENSIVE PEPTIDE; PROGNOSTIC VALUE; ACUTE DYSPNEA; PLASMA; PERFORMANCE; PRESSURE; SEPSIS;

D O I：

10.1016/j.atherosclerosis.2013.03.006

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Aims and background: Midregional proadrenomedullin (MR-proADM) is a protein, which exerts various effects on the cardiovascular system. Recent studies underscored its prognostic implications in patients with acute dyspnea and cardiovascular diseases. Therefore, we aimed to determine the distribution of MR-proADM in the general population and to reveal potential associations of MR-proADM with cardiovascular risk factors and measures of subclinical cardiovascular disease. Methods and results: MR-proADM plasma concentrations were determined in individuals of the population-based cohort of the Gutenberg Health Study (N = 5000) using a commercially available fluoroimmunoassay. Individuals were enrolled between April 2007 and October 2008. Subclinical cardiovascular disease was assessed using echocardiographic and functional measures of myocardial and vascular function. The mean age of the study population was 55.5 +/- 10.9 years. In the overall population we determined a median MR-proADM plasma concentration of 0.44 nmol/L in men and women. MR-proADM concentrations were elevated in individuals with hypertension, diabetes, dyslipidemia, known cardiovascular disease, heart failure, peripheral artery disease, atrial fibrillation, and history of myocardial infarction and stroke. In men, we observed a positive association of MR-proADM with reduced ejection fraction, intraventricular septal diameter, wall thickness, and echocardiographic measures of diastolic dysfunction. Conclusions: In this study, we present age-dependent reference values for MR-proADM in a representative population sample. Elevated MR-proADM plasma concentrations were strongly associated with classical cardiovascular risk factors and manifest cardiovascular diseases. Furthermore, we revealed a gender-specific association with echocardiographic measures of hypertension. MR-proADM seems to be a promising prognostic biomarker for subclinical and manifest cardiovascular disease. (C) 2013 Elsevier Ireland Ltd. All rights reserved.

引用

页码：451 / 459

页数：9

共 31 条

[1] Mid-Regional Pro-Adrenomedullin Is Associated With Pulse Pressure, Left Ventricular Mass, and Albuminuria in African Americans With Hypertension [J].

Al-Omari, Malik A. ;

Khaleghi, Mahyar ;

Mosley, Thomas H., Jr. ;

Turner, Stephen T. ;

Morgenthaler, Nils G. ;

Struck, Joachim ;

Bergmann, Andreas ;

Kullo, Iftikhar J. .

AMERICAN JOURNAL OF HYPERTENSION, 2009, 22 (08) :860-866

[2] Influence of confounding factors on plasma Mid-Regional pro-Adrenomedullin and Mid-Regional pro-A-type Natriuretic Peptide concentrations in healthy individuals [J].

Bhandari, Sanjay S. ;

Davies, J. E. ;

Struck, J. ;

Ng, L. L. .

BIOMARKERS, 2011, 16 (03) :281-287

[3] The midregional portion of proadrenomedullin is an independent predictor of left ventricular mass index in hypertension [J].

Bhandari, Sanjay S. ;

Davies, Joan E. ;

Struck, Joachim ;

Ng, Leong L. .

METABOLISM-CLINICAL AND EXPERIMENTAL, 2010, 59 (01) :7-13

[4] Characterization of an animal model of postmenopausal cardiac hypertrophy and novel mechanisms responsible for cardiac decompensation using ovariectomized pressure-overloaded rats [J].

Bhuiyan, Md. Shenuarin ;

Fukunaga, Kohji .

MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2010, 17 (01) :213-221

[5]

Brouwers FP, 2012, HEART

[6] Mid-regional pro-adrenomedullin as a prognostic marker in sepsis:: an observational study [J].

Christ-Crain, M ;

Morgenthaler, NG ;

Struck, J ;

Harbarth, S ;

Bergmann, A ;

Müller, B .

CRITICAL CARE, 2005, 9 (06) :R816-R824

[7] The effects of hormone replacement therapy on myocardial performance in early postmenopausal women [J].

Duzenli, M. A. ;

Ozdemir, K. ;

Sokmen, A. ;

Gezginc, K. ;

Soylu, A. ;

Celik, C. ;

Altunkeser, B. B. ;

Tokac, M. .

CLIMACTERIC, 2010, 13 (02) :157-170

[8] Diagnostic performance of mid-regional pro-adrenomedullin as an analyte for the exclusion of left ventricular dysfunction [J].

Elmas, Elif ;

Lang, Siegfried ;

Dempfle, Carl Erik ;

Kaelsch, Thorsten ;

Papassotiriou, Jana ;

Morgenthaler, Nils G. ;

Borggrefe, Martin ;

Brueckmann, Martina .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2008, 128 (01) :107-111

[9] HEMODYNAMIC-EFFECTS OF A NOVEL HYPOTENSIVE PEPTIDE, HUMAN ADRENOMEDULLIN, IN RATS [J].

ISHIYAMA, Y ;

KITAMURA, K ;

ICHIKI, Y ;

NAKAMURA, S ;

KIDA, O ;

KANGAWA, K ;

ETO, T .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 241 (2-3) :271-273

[10] RENAL LOCALIZATION AND ACTIONS OF ADRENOMEDULLIN - A NATRIURETIC PEPTIDE [J].

JOUGASAKI, M ;

WEI, CM ;

AARHUS, LL ;

HEUBLEIN, DM ;

SANDBERG, SM ;

BURNETT, JC .

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1995, 268 (04) :F657-F663

← 1 2 3 4 →